SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.74 CNY | +2.36% |
|
+6.44% | -12.50% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2023 | 1.05B 145M 199M | Sales 2024 * | 1.22B 170M 232M | Capitalization | 6.97B 967M 1.32B |
|---|---|---|---|---|---|
| Net income 2023 | 219M 30.39M 41.51M | Net income 2024 * | 270M 37.46M 51.18M | EV / Sales 2023 | 7.6 x |
| Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 5.7 x |
| P/E ratio 2023 |
36.4
x | P/E ratio 2024 * |
25.8
x | Employees | 796 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 22.24% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.36% | ||
| 1 week | +6.44% | ||
| Current month | +2.36% | ||
| 1 month | +6.51% | ||
| 3 months | +34.06% | ||
| 6 months | -12.12% | ||
| Current year | -12.50% |
1 week
28.12
31.03
1 month
26.7731.03
Current year
22.0535.40
1 year
22.0542.18
3 years
21.5042.88
5 years
19.2951.56
10 years
15.7851.56
| Managers | Title | Age | Since |
|---|---|---|---|
Cai Ping Guo
CEO | Chief Executive Officer | 53 | 93-12-31 |
Zhan Zhang
CHM | Chairman | 52 | 94-06-30 |
Sen Cai
BRD | Director/Board Member | 46 | 10-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ji Jiang Lin
BRD | Director/Board Member | 48 | - |
Shu Ying Sun
BRD | Director/Board Member | 51 | - |
Lu Zhang
BRD | Director/Board Member | 52 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-05 | 30.74 | +2.36% | 5 320 739 |
| 24-04-30 | 30.03 | +5.52% | 3,604,386 |
| 24-04-29 | 28.46 | -1.45% | 2,387,061 |
End-of-day quote Shenzhen S.E., May 05, 2024
More quotes
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS Co., Ltd. is a China-based high-tech company principally engaged in the research and development, production and sales of biological products. The Companyâs primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The Company mainly operates its businesses in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
30.74
CNY
Average target price
42
CNY
Spread / Average Target
+36.63%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.50% | 941M | |
| -3.89% | 88.14B | |
| +1.45% | 40.51B | |
| -14.71% | 31.67B | |
| +51.20% | 24.62B | |
| -15.11% | 15.65B | |
| -13.99% | 12.07B | |
| -7.87% | 11.97B | |
| -39.40% | 11.61B | |
| +5.62% | 8.81B |
- Stock Market
- Equities
- 002880 Stock